Sophia Genetics Raises $30m


Sophia Genetics, a data-driven healthcare startup backed by Autonomy billionaire Mike Lynch, has raised a $30 million D round (£23 million) for its medical software platform. The funding round brings total investment in the startup up to around $60 million (£45 million).

The funding round was led by London-headquartered venture capital firm Balderton Capital, together with 360 Capital. Existing investors Invoke Capital (Mike Lynch’s startup investment company), and Belgian pharmaceutical entrepreneur Mark Coucke also participated.

More information

Get our latest news & updates

Did you read our investment thesis correctly before sending us your application ?